Genetico is investing 50 million rubles in the startup Cardiogenex, which develops gene therapy drugs for the treatment of hereditary heart diseases. Startup uses the funds received to validate models of cardiomyopathic diseases, conduct animal studies to select the most effective candidate drugs for preclinical research. There are about 730,000 people with...

Ministry of Health has included the genetic examination of embryos for monogenic diseases (PGT-M) and structural chromosomal rearrangements (PGT-SP) in the standard IVF procedure for compulsory medical insurance. Such tests are recommended for patients who are at risk of having children with hereditary diseases.

Genetico's RAS loss for 9 months of 2025 amounted to ₽23.1 million, 4.3 times compared to ₽5.4 million in the previous year. Revenue increased by 37.4% to ₽408.1 million from ₽297 million a year earlier.

Regions will begin to conduct genetic tests when planning and managing pregnancy under the compulsory health insurance policy, according to the draft program of free medical care for 2026-2028. Preimplantation genetic testing of embryos will be added to the IVF procedure under compulsory medical insurance, which increases the frequency of pregnancy by more t...